中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2013年
8期
10-13
,共4页
王龙跃%段伟宏%朱震宇%陈军周%张涛%周宁新
王龍躍%段偉宏%硃震宇%陳軍週%張濤%週寧新
왕룡약%단위굉%주진우%진군주%장도%주저신
胰腺肿瘤%胰腺切除术%腹腔镜检查%Da Vinci机器人系统
胰腺腫瘤%胰腺切除術%腹腔鏡檢查%Da Vinci機器人繫統
이선종류%이선절제술%복강경검사%Da Vinci궤기인계통
Pancreatic neoplasms%Pancreatectomy%Laparoscopy%Da Vinci surgical system
目的 探讨Da Vinci机器人系统在远端胰腺肿瘤手术中的安全性与有效性.方法 回顾性总结分析14例Da Vinci机器人系统辅助下胰体尾部肿瘤手术患者的临床资料.结果 平均手术时间343.93(170～575)min,平均术中失血量192.5(10～700)ml,均未输血.术后病理检查结果:胰腺导管腺癌7例,黏液性囊腺瘤1例,浆液性囊腺瘤1例,黏液性囊腺瘤局部癌变1例,胰腺导管高级别上皮内瘤变1例,胰岛素瘤1例,实性假乳头状肿瘤2例.术后2例发生胰漏,经保守治疗好转.其余术后均恢复顺利,无并发症.术后平均住院10.64 d.结论 Da Vinci机器人系统辅助下远端胰腺手术为有效的治疗远端胰腺肿瘤的新术式,安全可行,具有微创优势.因国内外样本量较少,手术经验不足,需以后进行大样本、长期随访的高质量临床研究,并及时更新系统,评价其有效性和安全性.
目的 探討Da Vinci機器人繫統在遠耑胰腺腫瘤手術中的安全性與有效性.方法 迴顧性總結分析14例Da Vinci機器人繫統輔助下胰體尾部腫瘤手術患者的臨床資料.結果 平均手術時間343.93(170～575)min,平均術中失血量192.5(10～700)ml,均未輸血.術後病理檢查結果:胰腺導管腺癌7例,黏液性囊腺瘤1例,漿液性囊腺瘤1例,黏液性囊腺瘤跼部癌變1例,胰腺導管高級彆上皮內瘤變1例,胰島素瘤1例,實性假乳頭狀腫瘤2例.術後2例髮生胰漏,經保守治療好轉.其餘術後均恢複順利,無併髮癥.術後平均住院10.64 d.結論 Da Vinci機器人繫統輔助下遠耑胰腺手術為有效的治療遠耑胰腺腫瘤的新術式,安全可行,具有微創優勢.因國內外樣本量較少,手術經驗不足,需以後進行大樣本、長期隨訪的高質量臨床研究,併及時更新繫統,評價其有效性和安全性.
목적 탐토Da Vinci궤기인계통재원단이선종류수술중적안전성여유효성.방법 회고성총결분석14례Da Vinci궤기인계통보조하이체미부종류수술환자적림상자료.결과 평균수술시간343.93(170～575)min,평균술중실혈량192.5(10～700)ml,균미수혈.술후병리검사결과:이선도관선암7례,점액성낭선류1례,장액성낭선류1례,점액성낭선류국부암변1례,이선도관고급별상피내류변1례,이도소류1례,실성가유두상종류2례.술후2례발생이루,경보수치료호전.기여술후균회복순리,무병발증.술후평균주원10.64 d.결론 Da Vinci궤기인계통보조하원단이선수술위유효적치료원단이선종류적신술식,안전가행,구유미창우세.인국내외양본량교소,수술경험불족,수이후진행대양본、장기수방적고질량림상연구,병급시경신계통,평개기유효성화안전성.
Objective To explore the clinical safety and validity of Da Vinci surgical system in distal pancreatic tumor resection.Methods The clinical data of 14 patients with distal pancreatic tumor underwent robotic surgeries by using Da Vinci surgical system from January 2009 to June 2012 were retrospectively analyzed.Results The average operation time was 343.93 (170-575) min,average blood loss was 192.5 (10-700) ml,without blood trahsfusion.Pathologic examination showed:pancreatic ductal adenocarcinoma in 7 patients,pancreatic cystadenoma in 1 patient,mucous cystadenoma in 1 patient,cystadenocarcinoma in 1 patient,high levels of pancreatic ductal intraepithelial neoplasia in 1 patient,insulinoma in 1 patient,solid pseudo-papillary tumor in 2 patients.Two patients with pancreatic leaks after operation and then relieved after conservative medical therapy.Others were discharged from hospital without complications.The average hospital stay was 10.64 d.Conclusions Da Vinci surgical system is safe and effective in treatment for patients with distal pancreatic rumor with minimally invasive advantage.Because lack of surgical experience and small sample,a large sample with long term follow-up of high-quality clinical research is required and then update the system to evaluate the efficacy and safety.
